mRNA COVID-19 Vaccines Seen as Most Promising: GlobalData

Nearly 38 percent of healthcare participants felt that mRNA COVID-19 vaccines are the most promising of the vaccine technologies, noticeably beating DNA vaccines, according to GlobalData survey.

Around 38 percent of healthcare participants saw promising results in mRNA COVID-19 vaccines, according to GlobalData survey.

While mRNA may currently be leading the way, other vaccine candidates by Sanofi/GSK and AstraZeneca are soon catching up.

Emergency COVID-19 Vaccine Could be Ready by 2021
Emergency vaccine for coronavirus (COVID-19) can be ready by next January or February. mRNA vaccines represent a promising alternative to conventional vaccine approaches because of their high potency, capacity for rapid development and potential for low-cost manufacture and safe administration.

TOP INSIGHT

mRNA vaccines are the most promising among emerging COVID-19 vaccines.

Johanna Swanson, Product Manager at GlobalData, comments: “GSK is a world leader in the vaccine market and will have strong production, distribution, and support for the candidate. There will also be space for multiple vaccines on the market with different production methods.”

Moderna’s mRNA-1273 vaccine and BioNTech/Pfizer’s mRNA vaccine BNT162 have received a large amount of attention, while Moderna’s vaccine is currently one of the most promising vaccine candidates, as it has advanced into Phase III and has faster production times.

Swanson notes: “The interim results are encouraging, but more research is required into whether the neutralizing antibodies being produced can provide lasting immunity. So far, there are no approved mRNA vaccines, so this is an unproven method.

Health Experts React To Russian Covid Vaccine Cautiously
Cautiously after the news of Russia registering the world's first Covid-19 vaccine, Indian health experts stressed that it would be too early to say if it is safe or not as adequate testing didn't take place.

“The fact that DNA vaccines only accounted for 9% of the poll responses is interesting since they are also an unproven method, as no DNA vaccines have been approved for human use. This could represent Inovio’s DNA vaccine requiring a specialized unique administration device, which could be an obstacle for its use, and make them less favorable.”

Clinical Trials of Covid Vaccine Begins In India
For India's first indigenous Covid-19 vaccine, two volunteers were given its first dose at the Nizam's Institute of Medical Sciences (NIMS) on Monday.

Source-Medindia

COVID Vaccine to Cost Less Than Rs 250/dose: Serum Institute
Serum Institute of India has joined hands with Astra Zeneca and Novavax to develop their COVID-19 vaccine candidates.